New study checks if inhaled steroid is safe for Preemies' lungs

This early-stage study tests the safety of an inhaled steroid called ciclesonide in 30 premature babies who are on breathing machines and at risk for a chronic lung condition called bronchopulmonary dysplasia. Researchers will closely monitor side effects like high blood sugar, growth changes, and adrenal function, and measure how much of the drug gets into the babies' blood. The goal is to see if this treatment can be safely used to help prevent or ease lung disease in these vulnerable infants.